Lack of cross-resistance to fostriecin in a human small-cell lung carcinoma cell line showing topoisomerase II-related drug resistance. (Q41709053)

From Wikidata

Jump to navigation Jump to search

scientific article published on January 1991

edit

Language	Label	Description	Also known as
English	Lack of cross-resistance to fostriecin in a human small-cell lung carcinoma cell line showing topoisomerase II-related drug resistance.	scientific article published on January 1991

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1657425

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1657425%20AND%20SRC:MED&resulttype=core&format=json

retrieved

23 September 2019

title

Lack of cross-resistance to fostriecin in a human small-cell lung carcinoma cell line showing topoisomerase II-related drug resistance (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1657425

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1657425%20AND%20SRC:MED&resulttype=core&format=json

retrieved

23 September 2019

main subject

cell line

0 references

lung carcinoma

1 reference

based on heuristic

inferred from title

author

Elisabeth de Vries

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1657425

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1657425%20AND%20SRC:MED&resulttype=core&format=json

retrieved

23 September 2019

author name string

S de Jong

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1657425

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1657425%20AND%20SRC:MED&resulttype=core&format=json

retrieved

23 September 2019

J G Zijlstra

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1657425

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1657425%20AND%20SRC:MED&resulttype=core&format=json

retrieved

23 September 2019

N H Mulder

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1657425

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1657425%20AND%20SRC:MED&resulttype=core&format=json

retrieved

23 September 2019

publication date

1 January 1991

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1657425

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1657425%20AND%20SRC:MED&resulttype=core&format=json

retrieved

23 September 2019

published in

Cancer Chemotherapy and Pharmacology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1657425

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1657425%20AND%20SRC:MED&resulttype=core&format=json

retrieved

23 September 2019

volume

28

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1657425

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1657425%20AND%20SRC:MED&resulttype=core&format=json

retrieved

23 September 2019

issue

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1657425

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1657425%20AND%20SRC:MED&resulttype=core&format=json

retrieved

23 September 2019

page(s)

461-464

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1657425

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1657425%20AND%20SRC:MED&resulttype=core&format=json

retrieved

23 September 2019

describes a project that uses

GLC-4

0 references

GLC-4/ADR

0 references

GLC-4/CDDP

0 references

cites work

Multidrug resistance

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1657425

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Altered catalytic activity of and DNA cleavage by DNA topoisomerase II from human leukemic cells selected for resistance to VM-26.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1657425

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro and intracellular inhibition of topoisomerase II by the antitumor agent merbarone

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1657425

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activity of the novel antitumor antibiotic fostriecin (CI-920) in a human tumor cloning assay

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1657425

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced DNA topoisomerase II activity and drug-induced DNA cleavage activity in an adriamycin-resistant human small cell lung carcinoma cell line

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1657425

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of type II topoisomerase by fostriecin

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1657425

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DNA topoisomerase poisons as antitumor drugs

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1657425

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estrogen-induced potentiation of DNA damage and cytotoxicity in human breast cancer cells treated with topoisomerase II-interactive antitumor drugs

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1657425

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Resistance mechanisms in three human small cell lung cancer cell lines established from one patient during clinical follow-up

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1657425

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transport of the antitumor antibiotic Cl-920 into L1210 leukemia cells by the reduced folate carrier system

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1657425

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anticancer activity of the structurally novel antibiotic Cl-920 and its analogues

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1657425

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Direct correlation between DNA topoisomerase II activity and cytotoxicity in adriamycin-sensitive and -resistant P388 leukemia cell lines

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1657425

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms and clinical significance of multidrug resistance

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1657425

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined modalities of resistance in etoposide-resistant human KB cell lines.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1657425

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Altered function of DNA topoisomerases as a basis for antineoplastic drug action

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1657425

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of a human small cell lung carcinoma cell line with acquired resistance to cis-diamminedichloroplatinum(II) in vitro.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1657425

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DNA topoisomerases

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1657425

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Topoisomerases, new targets in cancer chemotherapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1657425

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Topoisomerase II-dependent and -independent mechanisms of etoposide resistance in Chinese hamster cell lines

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1657425

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DNA topoisomerase II is required at the time of mitosis in yeast

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1657425

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1657425

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multifactorial drug resistance in an adriamycin-resistant human small cell lung carcinoma cell line

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1657425

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biochemical basis for the interactions of type I and type II topoisomerases with DNA.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1657425

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergistic enhancement by tumor necrosis factor of in vitro cytotoxicity from chemotherapeutic drugs targeted at DNA topoisomerase II.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1657425

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug resistance in cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1657425

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/BF00685823

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1657425

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1657425%20AND%20SRC:MED&resulttype=core&format=json

retrieved

23 September 2019

Dimensions Publication ID

1021629100

0 references

PubMed publication ID

1657425

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1657425

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1657425%20AND%20SRC:MED&resulttype=core&format=json

retrieved

23 September 2019

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41709053&oldid=2204725000"